0
    Listing cover image
    Member of the Swiss Biotech Association Member

    Vir Biotechnology, Inc. (formerly Humabs BioMed AG) Verified listing Verified listing

    • Founded
      2017
    • Employees in Switzerland
      20-49

    Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on engineering antibodies into impactful medicines to treat infectious diseases and cancer. Since 2025, Humabs BioMed AG (acquired by Vir Biotechnology in 2017) operates with a unified brand with Vir Biotechnology.

    Location

    Additional address info

    • Vir Biotechnology, Inc. (correspondence Humabs BioMed AG)

    Canton

    Facts & figures

    • Type of organization
      Public company
    • Year of foundation
      2017
    • Number of employees in Switzerland
      20-49

    Key business

    Keep browsing

    You may also be interested in